Genentech’s Forecast: Biotech Pioneer Looking To Small Molecules

Genentech, one of the pioneers of the biotech industry, will be bringing a growing number of small molecules into the clinic as it seeks to diversify its pipeline, according to VP-Clinical Hematology/Oncology David Schenkein

More from Archive

More from Pink Sheet